Ironwood Pharmaceuticals: A Contrarian Buy Opportunity
Source: SeekingAlpha
2026-05-21 20:17:21 ET
Small- to mid-cap pharma stocks offer distinctive opportunities for contrarian investors able to look beyond short-term volatility and identify undervalued stocks with strong fundamental potential. In our view, Ironwood Pharmaceuticals, Inc. (IRWD), despite recent negative sentiment and management changes, represents an attractive buy based on its solid underlying business and attractive valuation....
Read the full article on Seeking Alpha
For further details see:
Ironwood Pharmaceuticals: A Contrarian Buy Opportunity
Ironwood Pharmaceuticals Inc.
NASDAQ: IRWD
IRWD Trading
1.17% G/L:
$3.465 Last:
243,063 Volume:
$3.365 Open:
IRWD Latest News
IRWD Stock Data
$754,015,529
142,018,459
0.3%
66
N/A
Pharmaceuticals
Healthcare
US
Boston
